Previous 10 | Next 10 |
2023-05-15 16:25:07 ET Trxade Group press release ( NASDAQ: MEDS ): Q1 GAAP EPS of -$0.03 in-line. Revenue of $2.25M (-30.6% Y/Y) misses by $0.41M . For further details see: Trxade Group GAAP EPS of -$0.03 in-line, revenue of $2.25M misses by $0.41M
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, May 15, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the “Company”), a health services IT company focused on digitalizing the retail ...
TRxADE Health (NASDAQ: MEDS) , a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is planning to report on its financial results for first quarter 2023 after...
TAMPA, FL / ACCESSWIRE / May 5, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the ...
TRxADE Health (NASDAQ: MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The company has announced that it will release its financial results for the first quart...
TAMPA, FL / ACCESSWIRE / April 25, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the...
TRxADE Health (NASDAQ: MEDS) , a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is reporting its financial results for the year ending Dec. 31, 2022. Highl...
2023-03-27 21:30:05 ET TRxADE HEALTH, Inc. (MEDS) Q4 2022 Earnings Conference Call March 27, 2023, 05:30 PM ET Company Participants Prashant Patel - CFO Surendra Ajjarapu - Founder, Chairman and CEO Conference Call Participants Allen Klee - Maxim Group ...
2023-03-27 16:42:26 ET Trxade Group press release ( NASDAQ: MEDS ): FY GAAP EPS of -$0.41 misses by $0.03 . Revenue of $11.4M (+15.2% Y/Y) misses by $0.03M . Operating expenses for the fiscal year of 2022 were $9.9 million, compared to $10 million in the fisc...
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL / ACCESSWIRE / March 27, 2023 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing dr...
News, Short Squeeze, Breakout and More Instantly...
TRxADE (NASDAQ: MEDS) today announced that its board of directors has declared a special cash dividend of $1.50 per share of common stock. According to the announcement, the special dividend is being paid using a portion of the proceeds received in May 2024 in connection with the prior sale of t...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 20.9% to $0.5541 on volume of 173,316,620 shares Assure Holdings Corp. (IONM) rose 114.1% to $0.496799 on volume of 118,668,589 shares NLS Pharmaceutics Ltd. (NLSP) rose 67.6% to $0...
TAMPA, FL, June 27, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. ( Nasdaq: MEDS ) (the “ Company ”), announced today that with the filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”), the Company regained complianc...